Have an upcoming challenging Investigational Medicinal Product (IMP) project and don’t know where to turn for advice? Worry no more - attend the Investigational Medicinal Product track at the ISPE Europe Annual Conference in Frankfurt, Germany on 7 – 9 March 2016 and you will be amazed by the plethora of solutions you will take back to your company. I have been an ISPE member for many years and always look forward to the Europe Annual Conference. The conference is designed by IMP professionals for IMP professionals– and it’s always great to network with life-long connections and create some new ones along the way. But the REAL bonuses are the solutions based presentations and forums and receiving innovative ideas from conference attendees for that difficult problem back home – there is always someone else who has tackled your problem. Innovation and patient centric are the focus for the Europe Annual Conference. A couple of the sessions I can’t wait to hear about include:
So don’t just sit there – register now and we look forward to seeing you at the 2016 Europe Annual Conference!
ISPE hosted more than 450 attendees in person and virtually for the 2024 ISPE Aseptic Conference in Vienna, Austria. Keynotes and education sessions provided a comprehensive overview of key topics and trends...
Biopharmaceutical facility design is a critical aspect of the industry. Overall cost pressures in the global health system, regional requirements to deploy manufacturing rather than centralize manufacturing in one location, technology enhancements in cell biology and format, flexibility to accommodate multi-product campaigns with different production schedules, and speed-to-market are among...
The biotechnology industry continues to evolve, advancing the frontiers of science and engineering in the design, development, and manufacture of a wide variety of therapeutic modalities. Advances in cell and gene therapies continue to offer treatments for diseases that were previously uncurable, with seven approvals in 2023, including treatments for sickle-cell disease, hemophilia, type 1...